Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Feb 28 (Reuters) - Bio Vitos Pharma AB BIOVIT.ST: Q4 OPERATING REVENUE SEK 0.3 MILLION VERSUS SEK 1.0 MILLION YEAR AGO Q4 PRE-TAX LOSS SEK 16.7 MILLION Source text: ID:nWkr2KlxFj Further company coverage: BIOVIT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln